oxcarbazepine
oxcarbazepine is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand names including Oxcarbazepine, Trileptal, oxcarbazepine. Available dosage forms: tablet, film coated, suspension, tablet, powder, for suspension.
Drug Details
- Generic Name
- oxcarbazepine
- Brand Names
- Oxcarbazepine, Trileptal, oxcarbazepine
- Application Number
- ANDA077747
- Sponsor
- Advagen Pharma Limited
- NDC Codes
- 16
- Dosage Forms
- TABLET, FILM COATED, SUSPENSION, TABLET, POWDER, FOR SUSPENSION
- Routes
- ORAL
- Active Ingredients
- OXCARBAZEPINE
Indications and Usage
1 INDICATIONS AND USAGE Oxcarbazepine tablets is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures. Oxcarbazepine tablets is indicated for: Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures Pediatrics: Monotherapy in the treatment of partial-onset seizures in children 4–16 years Adjunctive therapy in the treatment of partial-onset seizures in children 2–16 years ( 1 )